MedPath

AURO-LACOSAMIDE

AURO-LACOSAMIDE

Approved
DIN Number

02475359

Drug Class

Human

Market Date

Oct 1, 2018

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02475359
AIG Number0152810003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX18 LACOSAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LACOSAMIDEActive
Strength: 150 MG
Monograph: LACOSAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.